#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	4276	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2307	547.3	0	.	n	.	0	C1450T	SNP	1450	1450	C	1761	1761	T	634	T	565	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	4276	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2307	547.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1495	1495	C	658	C	577	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	4276	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2307	547.3	0	HET	.	.	.	A922G	.	922	922	A	1233	1233	A	658	A,G	450,134	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6858	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3962	519.4	0	.	n	.	0	G1337A	SNP	1337	1337	G	1850	1850	A	626	A,G	551,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6858	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3962	519.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2484	2484	C	637	C	569	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6858	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3962	519.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2558	2558	A	659	A,G	566,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6858	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3962	519.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	3110	3110	C	579	C,T,A	500,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6858	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3962	519.4	0	HET	.	.	.	C993T	.	993	993	C	1506	1506	C	546	C,T	351,105	.	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	27	726	folP	852	852	99.88	folP.l15.c4.ctg.1	1891	115.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1528	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3729	123.1	1	SNP	p	S91F	0	.	.	271	273	TCC	757	759	TCC	132;133;134	T;C;C	120;119;119	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1528	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3729	123.1	1	SNP	p	D95G	0	.	.	283	285	GAC	769	771	GAC	134;135;135	G;A;C	120;121;122	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1528	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3729	123.1	1	SNP	p	D95N	0	.	.	283	285	GAC	769	771	GAC	134;135;135	G;A;C	120;121;122	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	606	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1601	113.6	0	.	p	.	0	A39T	NONSYN	115	117	GCC	617	619	ACC	164;164;163	A;C;C,T	148;146;147,1	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	606	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1601	113.6	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	815	817	CAC	152;152;154	C;A;C	131;132;133	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	606	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1601	113.6	0	.	p	.	0	E117K	NONSYN	349	351	GAA	851	853	AAA	148;148;150	A,G;A;A,C	132,1;133;133,1	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	606	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1601	113.6	1	SNP	p	G45D	0	.	.	133	135	GGC	635	637	GGC	163;163;164	G;G;C	146;147;148	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	454	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1279	106.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1398	parC	2304	2304	99.7	parC.l15.c17.ctg.1	3167	132.1	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1512	1514	ATC	178;178;176	A;T;C	146;147;146	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1398	parC	2304	2304	99.7	parC.l15.c17.ctg.1	3167	132.1	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1665	1667	GCA	168;169;169	G;C;A	145;145;146	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1398	parC	2304	2304	99.7	parC.l15.c17.ctg.1	3167	132.1	0	.	p	.	0	V596I	NONSYN	1786	1788	GTT	2148	2150	ATT	154;154;154	A;T;T	134;135;135	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1398	parC	2304	2304	99.7	parC.l15.c17.ctg.1	3167	132.1	1	SNP	p	D86N	0	.	.	256	258	GAC	618	620	GAC	147;148;148	G;A;C	130;129;131	parC.WHO_F_01444:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1398	parC	2304	2304	99.7	parC.l15.c17.ctg.1	3167	132.1	1	SNP	p	S87I	0	.	.	259	261	AGT	621	623	AGT	147;148;148	A;G;T	129;132;132	parC.WHO_F_01444:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1398	parC	2304	2304	99.7	parC.l15.c17.ctg.1	3167	132.1	1	SNP	p	S87R	0	.	.	259	261	AGT	621	623	AGT	147;148;148	A;G;T	129;132;132	parC.WHO_F_01444:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1398	parC	2304	2304	99.7	parC.l15.c17.ctg.1	3167	132.1	1	SNP	p	S87W	0	.	.	259	261	AGT	621	623	AGT	147;148;148	A;G;T	129;132;132	parC.WHO_F_01444:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1398	parC	2304	2304	99.7	parC.l15.c17.ctg.1	3167	132.1	1	SNP	p	S88P	0	.	.	262	264	TCC	624	626	TCC	149;149;149	T;C;C	131;132;133	parC.WHO_F_01444:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1378	parE	1986	1986	99.9	parE.l15.c17.ctg.1	2961	139.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1735	1737	GGC	173;170;172	G;G;C	154;147;148	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.002	penA.22.002	1	1	27	1354	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2679	151.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1425	1427	GCA	227;228;230	G;C;A	195;197;196	penA.22.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	1354	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2679	151.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1428	1430	ATC	233;232;235	A,C;T;C	196,1;195;195	penA.22.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	1354	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2679	151.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1440	1442	GTG	238;236;234	G;T;G,C	200;199;196,1	penA.22.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	1354	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2679	151.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1440	1442	GTG	238;236;234	G;T;G,C	200;199;196,1	penA.22.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	1354	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2679	151.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1944	1946	ACC	158;159;159	A;C;C,A	138;138;137,1	penA.22.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	1354	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2679	151.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1998	2000	GCG	156;155;155	G;C,G;G,C	134;121,1;130,1	penA.22.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	1354	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2679	151.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1998	2000	GCG	156;155;155	G;C,G;G,C	134;121,1;130,1	penA.22.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	1354	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2679	151.4	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2121	2123	GGT	177;176;177	G;G;T	150;151;150	penA.22.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	1354	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2679	151.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2130	2132	GGC	178;179;178	G;G;C	149;149;148	penA.22.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	1354	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2679	151.4	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2148	2150	CCG	174;175;176	C;C,G;G	147;154,1;151	penA.22.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	1482	ponA	2397	2397	99.96	ponA.l6.c17.ctg.1	3371	131.9	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1749	1751	CTG	152;153;155	C;T,G,C;G,A	130;131,1,1;132,1	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	790	porA	1146	1146	99.65	porA.l6.c4.ctg.1	2163	109.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	734	734	C	150	C	127	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	816	porB1b	1047	1047	99.04	porB1b.l15.c30.ctg.1	1678	137.8	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	855	857	CAA	181;179;179	C;A;A	159;160;157	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	816	porB1b	1047	1047	99.04	porB1b.l15.c30.ctg.1	1678	137.8	0	.	p	.	0	E212G	NONSYN	634	636	GAA	1062	1064	GGT	182;181;180	G;G;T	154;153;153	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	816	porB1b	1047	1047	99.04	porB1b.l15.c30.ctg.1	1678	137.8	0	.	p	.	0	H213D	NONSYN	637	639	CAT	1065	1067	GAT	181;181;181	G;A;T	154;152;152	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	816	porB1b	1047	1047	99.04	porB1b.l15.c30.ctg.1	1678	137.8	0	.	p	.	0	V215A	NONSYN	643	645	GTT	1071	1073	GCT	180;180;179	G;C;T	153;153;150	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	816	porB1b	1047	1047	99.04	porB1b.l15.c30.ctg.1	1678	137.8	0	.	p	.	0	I218M	NONSYN	652	654	ATC	1080	1082	ATG	179;179;181	A;T;G	149;150;149	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	816	porB1b	1047	1047	99.04	porB1b.l15.c30.ctg.1	1678	137.8	0	.	p	.	0	R257K	NONSYN	769	771	AGG	1197	1199	AAG	167;167;166	A;A;G	141;144;141	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	816	porB1b	1047	1047	99.04	porB1b.l15.c30.ctg.1	1678	137.8	1	SNP	p	G120K	0	.	.	358	360	GGC	786	788	GGC	179;181;181	G;G;C	145;150;149	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	2916	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5185	168.9	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2155	2157	CAT	201;199;199	C;A;T	169;169;173	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_F_02142c	rpsJ.WHO_F_02142c	1	1	27	440	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1351	97.8	1	SNP	p	V57M	0	.	.	169	171	GTG	701	703	GTG	191;191;190	G,A;T;G	159,1;161;160	rpsJ.WHO_F_02142c:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
